Abstract
Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccine therapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.
| Original language | English |
|---|---|
| Pages (from-to) | 591-596 |
| Number of pages | 6 |
| Journal | Recenti Progressi in Medicina |
| Volume | 85 |
| Issue number | 12 |
| Publication status | Published - 1994 |
Fingerprint
Keywords
- solid tumors
- specific immunotherapy
- vaccine therapy
ASJC Scopus subject areas
- Medicine(all)
Cite this
Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy. / Tagliaferri, F.; Sirovich, I.; Stipa, F.; Giovanna Valente, M.; Pupelis, G.; Tremiterra, S.
In: Recenti Progressi in Medicina, Vol. 85, No. 12, 1994, p. 591-596.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccine therapy
AU - Tagliaferri, F.
AU - Sirovich, I.
AU - Stipa, F.
AU - Giovanna Valente, M.
AU - Pupelis, G.
AU - Tremiterra, S.
PY - 1994
Y1 - 1994
N2 - Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccine therapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.
AB - Augmentation of specific immunity is one of the most promising immunotherapeutical approaches against solid tumors. Protocols using autologous tumor cells or tumor associated antigens are easily performed and not charged by severe side effects. Recently some clinical trials suggested good results from immunotherapeutical protocols applied as an adjuvant to surgery in terms of disease free interval, survival and progression time in different stages. In this review the authors report the results of the most important clinical trials of vaccine therapy in solid tumors. Little is known about the possibility of this new approach to oncology since we are at the real beginning of a new clinical treatment but in the considered trial its effectiveness seems to suggest a future wider application.
KW - solid tumors
KW - specific immunotherapy
KW - vaccine therapy
UR - http://www.scopus.com/inward/record.url?scp=0028574347&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028574347&partnerID=8YFLogxK
M3 - Article
C2 - 7899685
AN - SCOPUS:0028574347
VL - 85
SP - 591
EP - 596
JO - Recenti Progressi in Medicina
JF - Recenti Progressi in Medicina
SN - 0034-1193
IS - 12
ER -